pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1268b |
Genomic Coordinates | chr17: 80098828 - 80098877 |
Description | Homo sapiens miR-1268b stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1268b | |||||||||||||||||||||||||||||||||||||||||||||
Sequence | 4| CGGGCGUGGUGGUGGGGGUG |23 | |||||||||||||||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||||||||||||||
Experiments | Illumina | |||||||||||||||||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FRMPD4 | ||||||||||||||||||||
Synonyms | MRX104, PDZD10, PDZK10 | ||||||||||||||||||||
Description | FERM and PDZ domain containing 4 | ||||||||||||||||||||
Transcript | NM_014728 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FRMPD4 | |||||||||||||||||||||
3'UTR of FRMPD4 (miRNA target sites are highlighted) |
>FRMPD4|NM_014728|3'UTR 1 CTTTGACAGAGCCTGGGAAGGAGAGACGAGGAGGCATGCCTTCAGCTTGGTCTCAACATCCTGAAGCTGATCCCATCCTG 81 CTACCATCAAACATTCACTCGGAATCAAAGGTGCCAATTCCAAATCAAGACCCTAATGATTTCTCCCAAGCAAATCAGGC 161 ATACGGAGAGGCTGTGAGCTGGCGGCCACCGGATCTGAGAGGGGGGAGCCTCAGGACACCTCCCAGCCAGAAGGCTCTGA 241 GACATAGCAGCAGTATCCTCTCCGGATCTGTCGATTTGGAGACCTTCCGAGAGAGAACCAAGGGTGCAGTCAGCTTAAAG 321 TGTCCAGGCATCACAGAAGCACAGGAGGCCAGTTCTGAAAGGCGAGCAGAACTCCCCCTGGGGAGGAAGCTCACCAAAAG 401 TTTTTCCCAAAGCTCAATGCACTTGAGCTCTGAGGGGAGGTTTCACAAAAGGTCCCCAGTGGCTCATAAAGACTCAAAGC 481 TGTATAGGACATTACCCTTGCGGAAGCTGGAGGGCAGCAATTGGAGATGCCGGGGACCCTTCAGCTATTGCTTCCTGAAC 561 CGAGGGCAGGATGAAGATGGTGAGGAAGAAGAGGAGAGGGGAGAGGCCACCGTCCAGGTCTCTTGCCTCTATAGACCACA 641 GATGACTCAAGCCATGCCAGAACCAAGCAGCCCATGCCTGGCTGTGGCGATTCAGAAGCAACGAGGGGAGCTATCCAGAG 721 GGTCAGTGCTGAAGGTCTGGGCAGAAGACCTGCGAGACCCAGATGACTTGGACTTCAGCAACCTGGCTTTTGATGCCCGG 801 ATTGCAAGAATAAATGCCCTAAAGGAGAGCACATATGCAATGCCTGATGGGTTCCTTGCAGCCCAAAATGATGCCAATGA 881 GCTGCTCTGTCTCGTCAGGGCAACCAAGGAGAAGAGGGAGGAGTCACGCCCTGAAGCGTACGACCTTACACTTTCTCAGT 961 ACAAGCAACTGTTATCCATTGAGTCCAGACAGTTGGGAAGTGCCTGTAGGAAAATGGCGATGGCTGAGAAAAGCCCGGAG 1041 GAGATGCTCCTAGCTATGACTTCCAGCTTTCAAGTGCTCTGTTGCCTAACAGAAGCTTGCATGCGATTAGTTAAAGTCGT 1121 GAACTCAGAAACACAGCGGCAGGAAATTGTAGGGAAGATCGATGAAGTGGTCATAAATTACATTTGTCTACTGAAAGCTG 1201 CCGAAGCAGCCACTGGAAAGAACCCTGGGGACCCTAATGTTGGACTCTCGGCGCGACACTCAACCACCATGGCCGCTCTC 1281 GTAAGCACACTGACACGTTCTCTCAAGAGGCTTTTAAACAAATAAATATGGAAGTCACGTCATAATCTACCTTTGCAAAG 1361 CCATACATGAACTTTTATTTACTTTGTGTGTATGATGAACAGATGTCTCCTTTCTTCTCTCTGTATATTTTGTTATTTTA 1441 TATAAAATAGGAGATAAAAGTCACATTGATGAAATGTTGAAATGTACTAATCAGATGTATTCTGTTTATATTATACATAT 1521 ATATACACGTAAAAGAAATATCCAAGAAAGTGATGACATTTGGCTATTTTTCATATAGTTAAAACTCCAGGTATATGATG 1601 TGAAATTTTAAATTCTACCATGTTAGAGCAAAACAATGAATCCTATCCCCTTTCTTTCCAAGTAGCTACTTGGAAACCAT 1681 ATCATTCATATTTAGAAGTAAAACACAAAACAAAAAAGAGAGAGAAAAGAAAAGAAATCACAATGTATATAAAACAGTAC 1761 TTATGTTTTAAAATTATGATTTTTAAGCATTGGAAATAGCAAAAAGACATTTAAAATTCAAGAAGCTATTATGAATTACT 1841 AGAGAATATATCTGTAATAAATTAATTTTTTGCTCATAGTATTTGGTTACTGGATGCTTTCTTCCAAGAATCCCACATAT 1921 TTAATTTGGGTTTTTGCTACTGGGGCTACAAATTGGTGGGGATGGATTCTACTGTGTCAGCACAAATGCTCTTCACAGTG 2001 GTTCTAGCATTTAAAAAACTTCCCGGGGAGAAGAACAGAGGGGATGATGGGCAGTTTCCTAGGTAACACCTAGAGTTATA 2081 GAATATCTCATTACATAAAATGTATGGAATTAATAATACCAAAATTAATTATTTGATGGAAAGATCTGCTTTGACTAAAT 2161 GTCAAAAATCTGCAAACCAAAGACATTATCTTCCCCTCATCCCAACTCAACTACGAAACTTAAAATTCCCTTTAGAGTGA 2241 TAGGACATTTAGTAAAGTATTTGCAAACTTAAAAAAAGGAACATTTAATGATCATCAAAATTAAGTACAGATTCAGTAAT 2321 GTAGACCAGACCACACACCAGCACCTGTGAGTCTCATCTCAGATCACAGCTCTCAGCATAGGGCTTCATGCATCACCGCC 2401 TCTACAGAGGCTAAGGCTGCCAGTCAAATTTGGAATTATAGCGTAGTACTGGGACAAAATCTCAAATCTTGGATGTTCCA 2481 GAAAATCAGGGAGAGATGGCTACTGTAATCATGGGAGCCATGAGTAAATAGTTAAGTATTTATTAAATAAATACTTAATC 2561 TGGATTGGCTGATAAAAATATGAAATCTGAAAAAAAAAAGAAAGAAATGGAAGTGGTATATTTGACCAGTTCAAGTGAAA 2641 CCAATGGAATGCAAAGAACTTTCCAGGACTGTCACATCTCTAAAAGTACCCTGCAGTCATAAAATAAAATCGATATGTAT 2721 ATATGTATTTCCTGGGTCATTCAGTGCTCAAGTTACATGCACTCCTACTTAGACAGGTGGCTCCTTAAGAACATGATGGG 2801 AGTACACCAGGTGCAAATATTTCTACTTTTGTAGCCTGCTGAGAAGGAGTCATAACACAGTCCACAATTGCAATCTCTCT 2881 CTAGTCAGCCATTCCACAGGGACTCAACAACAAAAGCCGCACGTGGTTATGGATGGCAGCAAAGGAAAGGAGTTTAGGTG 2961 TGTGTTATTATAAATAATGTTTAACTAAATAATAAAACATTATTTCATTACAATTATAATTATAAATATTGGTGTTTTGA 3041 TATTGAGAGATATTAGTGGTGTTTACTGTGGAAAATCTTAGTAAATATCATTCTGTGTACTAAAATCCTAACCTATTAAT 3121 AGGATGTGTGCCCTATGTCAGACAGTGTGCTAAGCATATTAACTATATTATCTCATTTAATCATCACAACAATCTGCTGG 3201 TTTGGACACTATTCTCTCTGGAGGCAATATGGATGAGTTCTTACGGATATGGGGTTTGGGGTCAGAAACATCTTGATTAA 3281 AATTTTGACTCTGCCATTTTCTAGCCCTTTTATGTTGGGAAAGCTACTTTTTCTAGTCTCAATTTCCTCATAATAAAATG 3361 AAAATCAATTATAAGATCGATTTCCATAGGGTTGTCATGAGTTTTGAGTAAAAATGTGTATGTAAAGTTCTTACCACAAT 3441 ACCTGGCAGAGAGTAAGTATTCAATTAATGTTAGCTATTATTATCATCATAATCGTTGTGTTAAATATATTGCCCAAGAT 3521 AATATGTGGGGGAATGTTTGTTTTATATGCATATTGTATCCTGACTGTGTGCAGAACACATTATGTGTATTGCATATATG 3601 TAAAAGAAGTGTACAAGGAAGTGGCCATCCTTGTTCAAGTTACGTATCTAGTTAGAACAACTTCCCAGTCCATTGGAGTT 3681 CTTTGAGAAGCCTCAGGGAAGTAGCTCTGGGTCCTTCTAATCAACCTCCCATTACTGCGCCAGTAAGTTTCTGTTTCTTA 3761 TAAATAAACTCTTTGCTATTCAGAAAACCTCAAGGGGCCCCCACATTCACTAAGCATGGGGCTCCTAACTGGGGTCCAGG 3841 TCCATAGAGTGTAGGAAGAACATATTAGAACAATACTTGTGCTTATTTTTATCTAGCTTTTTTATGTTTGTGTATGTTTT 3921 ATAATGGCATAATAGTACAATGGTACATGTACATAATTTTAAATAAATAAATGAATGAATGAATAAATAAAAAAAAAAAA 4001 AA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
HITS-CLIP data was present in GSM1084066. RNA binding protein: AGO2. Condition:CLIP_noemetine_SantaCruzAb
HITS-CLIP data was present in GSM1084079. RNA binding protein: AGO2. Condition:CLIP_hippuristanol_rep2_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000380682.1 | 3UTR | AGAAGAGGGAGGAGUCAC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1084066 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_noemetine_SantaCruzAb |
Location of target site | ENST00000380682.1 | 3UTR | AGAAGAGGGAGGAGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1084079 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_hippuristanol_rep2_AbnovaAb |
Location of target site | ENST00000380682.1 | 3UTR | AGAAGAGGGAGGAGUC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
40 hsa-miR-1268b Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT473716 | MAPK1 | mitogen-activated protein kinase 1 | 2 | 2 | ||||||||
MIRT483653 | QSOX2 | quiescin sulfhydryl oxidase 2 | 2 | 4 | ||||||||
MIRT484276 | AIP | aryl hydrocarbon receptor interacting protein | 2 | 4 | ||||||||
MIRT486673 | WDR81 | WD repeat domain 81 | 2 | 2 | ||||||||
MIRT488670 | WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 2 | 4 | ||||||||
MIRT493452 | ITFG3 | family with sequence similarity 234 member A | 2 | 2 | ||||||||
MIRT495901 | ZNF641 | zinc finger protein 641 | 2 | 2 | ||||||||
MIRT500187 | BARX1 | BARX homeobox 1 | 2 | 4 | ||||||||
MIRT512014 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT521132 | SGPL1 | sphingosine-1-phosphate lyase 1 | 2 | 4 | ||||||||
MIRT530046 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT531518 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT543735 | DHCR7 | 7-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT558053 | EVI5L | ecotropic viral integration site 5 like | 2 | 2 | ||||||||
MIRT569602 | TRIM29 | tripartite motif containing 29 | 2 | 2 | ||||||||
MIRT570025 | FAM228A | family with sequence similarity 228 member A | 2 | 2 | ||||||||
MIRT573593 | CERS1 | ceramide synthase 1 | 2 | 2 | ||||||||
MIRT623883 | FRMPD4 | FERM and PDZ domain containing 4 | 2 | 2 | ||||||||
MIRT629999 | PDE6B | phosphodiesterase 6B | 2 | 2 | ||||||||
MIRT632715 | MSANTD4 | Myb/SANT DNA binding domain containing 4 with coiled-coils | 2 | 2 | ||||||||
MIRT633496 | ERO1L | endoplasmic reticulum oxidoreductase 1 alpha | 1 | 1 | ||||||||
MIRT637075 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT638182 | TLN1 | talin 1 | 2 | 2 | ||||||||
MIRT638766 | EPB41 | erythrocyte membrane protein band 4.1 | 2 | 2 | ||||||||
MIRT668072 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT669873 | RAET1E | retinoic acid early transcript 1E | 2 | 2 | ||||||||
MIRT670663 | KIAA1551 | KIAA1551 | 2 | 2 | ||||||||
MIRT671282 | RPL37A | ribosomal protein L37a | 2 | 2 | ||||||||
MIRT675054 | OR7D2 | olfactory receptor family 7 subfamily D member 2 | 2 | 2 | ||||||||
MIRT682783 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 2 | ||||||||
MIRT683343 | SCARF1 | scavenger receptor class F member 1 | 2 | 2 | ||||||||
MIRT690282 | ZNF154 | zinc finger protein 154 | 2 | 2 | ||||||||
MIRT695171 | SLC25A33 | solute carrier family 25 member 33 | 2 | 2 | ||||||||
MIRT695221 | SCAMP3 | secretory carrier membrane protein 3 | 2 | 2 | ||||||||
MIRT700484 | PTPRF | protein tyrosine phosphatase, receptor type F | 2 | 2 | ||||||||
MIRT700600 | PRKCA | protein kinase C alpha | 2 | 2 | ||||||||
MIRT701409 | NKRF | NFKB repressing factor | 2 | 2 | ||||||||
MIRT703994 | EIF5A2 | eukaryotic translation initiation factor 5A2 | 2 | 2 | ||||||||
MIRT711231 | RETSAT | retinol saturase | 2 | 2 | ||||||||
MIRT719509 | TMEM175 | transmembrane protein 175 | 2 | 2 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|